Tarsons Products Limited (IN:TARSONS)
:TARSONS
TARSONS Stock Chart & Stats
₹230.25
-₹6.55(-1.58%)
At close: 4:00 PM EST
₹230.25
-₹6.55(-1.58%)
Day’s Range― - ―
52-Week Range₹164.15 - ₹457.25
Previous CloseN/A
Volume39.72K
Average Volume (3M)2.32K
Market Cap
₹9.70B
Enterprise Value₹13.42B
Total Cash (Recent Filing)₹313.56M
Total Debt (Recent Filing)₹3.96B
Price to Earnings (P/E)61.6
Beta0.73
Next Earnings
May 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.86%
Share Statistics
EPS (TTM)0.50
Shares Outstanding53,206,280
10 Day Avg. Volume1,556
30 Day Avg. Volume2,322
Financial Highlights & Ratios
PEG Ratio-2.10
Price to Book (P/B)2.99
Price to Sales (P/S)4.79
P/FCF Ratio-34.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)11.7
Revenue Forecast (FY)₹4.88B
Bulls Say, Bears Say
Bulls Say
Recurring Consumables Business ModelTarsons' core revenue comes from consumable labware used repeatedly across research, diagnostics and pharma. Recurring replacement demand and broad end-market exposure create predictable, repeatable revenue streams, supporting durable top-line stability over months.
Strong Revenue Growth TrendA ~32.4% year-over-year revenue increase signals successful market penetration and expanding customer adoption. Sustained high revenue growth provides capacity to scale operations, absorb fixed costs, and fund incremental product or geographic expansion over the 2-6 month horizon.
Healthy Gross And EBITDA MarginsRobust gross and EBITDA margins indicate effective cost control and operational efficiency, supported by in-house manufacturing. These margins create financial buffer to invest in product breadth and distribution, improving resilience and long-term margin sustainability.
Bears Say
Negative Free Cash FlowNegative free cash flow in 2025 suggests capital spending or working-capital use outpaced operating cash generation. Persisting FCF deficits can constrain reinvestment, force external financing, and weaken liquidity, posing a structural risk to durable funding of growth initiatives.
Low Return On EquityAn ROE of 4.7% indicates limited efficiency in converting shareholder capital into profits. Despite revenue growth, low ROE signals potential capital allocation or margin shortcomings that could limit long-term shareholder value creation absent operational improvements.
Declining EPSA roughly 32% decline in EPS points to earnings volatility and weaker per-share profitability. This deterioration could reflect margin pressure, higher costs, or one-off items, reducing retained earnings and limiting ability to fund expansion or return cash to shareholders over time.
Tarsons Products Limited News
TARSONS FAQ
What was Tarsons Products Limited’s price range in the past 12 months?
Tarsons Products Limited lowest stock price was ₹164.15 and its highest was ₹457.25 in the past 12 months.
What is Tarsons Products Limited’s market cap?
Tarsons Products Limited’s market cap is ₹9.70B.
When is Tarsons Products Limited’s upcoming earnings report date?
Tarsons Products Limited’s upcoming earnings report date is May 25, 2026 which is in 49 days.
How were Tarsons Products Limited’s earnings last quarter?
Tarsons Products Limited released its earnings results on Feb 06, 2026. The company reported ₹0.5 earnings per share for the quarter, the consensus estimate of ₹0.5 by ₹0.
Is Tarsons Products Limited overvalued?
According to Wall Street analysts Tarsons Products Limited’s price is currently Overvalued.
Does Tarsons Products Limited pay dividends?
Tarsons Products Limited pays a Notavailable dividend of ₹2 which represents an annual dividend yield of 0.86%. See more information on Tarsons Products Limited dividends here
What is Tarsons Products Limited’s EPS estimate?
Tarsons Products Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tarsons Products Limited have?
Tarsons Products Limited has 53,206,280 shares outstanding.
What happened to Tarsons Products Limited’s price movement after its last earnings report?
Tarsons Products Limited reported an EPS of ₹0.5 in its last earnings report, expectations of ₹0.5. Following the earnings report the stock price went up 7.105%.
Which hedge fund is a major shareholder of Tarsons Products Limited?
Currently, no hedge funds are holding shares in IN:TARSONS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tarsons Products Limited
Tarsons Products Limited engages in the manufacturing and trading of plastic laboratory products and scientific instruments in India and internationally. The company's products include disposable plastic labware, centrifuge ware, cryo labware, liquid handling systems, and safety products and instruments; and bottles, carboys, measuring cylinder, cell culture products, electrophoresis, microscopy and microbiology products, vacuum desiccators, mini coolers, cryo boxes, breakers, test tube racks, pipette tips, petri dish, centrifuge tubes, cryogenic and storage vials, pasteur pipettes, vortex, and other products. Its products are used in molecular biology, cell culture, genomics, proteomics, and immunology. The company was incorporated in 1983 and is headquartered in Kolkata, India.
Technical Analysis
GRM Overseas Ltd.
―
―
Huhtamaki India Limited
―
Ice Make Refrigeration Ltd.
―
Stove Kraft Ltd.
―